Michael Recht

Title: Michael Recht: Innovator in Interferon Production

Introduction

Michael Recht, an accomplished inventor based in New Haven, CT, has made significant contributions to the field of biotechnology. He is renowned for his innovative methods in the production of interferon, a critical protein for immune response and therapeutic applications. With a single patent to his name, Recht continues to influence the scientific community through his research.

Latest Patents

Michael Recht holds a patent titled "Production of IFN using DA15 peptide," which details an in vitro method for the production of interferon. This groundbreaking method involves the culture of monocytes with a novel DA15 peptide, produced in Daudi cell lines, in response to stimulation with interferon gamma. This innovation presents a significant advancement in the efficiency and efficacy of interferon production.

Career Highlights

Currently, Michael Recht is affiliated with the Medical College of Wisconsin, Inc., where he has dedicated his career to advancing medical science and research. His work focuses on the implications of interferon in therapeutic settings, marking him as a prominent figure in his field.

Collaborations

Throughout his career, Michael Recht has collaborated with notable professionals, including Ernest C. Borden and Ernest Knight, Jr. These partnerships have fostered a collaborative environment that has enhanced research output and innovation in the study and application of interferon.

Conclusion

Michael Recht exemplifies the spirit of innovation in the biotechnology sector. Through his patent and collaborative efforts, he continues to pave the way for advancements in medical research and applications. His work not only contributes to the scientific community but also has the potential to impact patient therapies in the future.